Replies to post #174040 on Cytodyn Inc (CYDY)

[kevindenver]

Thank you! Sure seems hard to get a non-hype driven answer.

LL HIV combo trial met endpoints. Poor management execution and pivot to CoVID has kept this from approval. May or may not work for CoVID…yet to be clinically proven, again based on poor management execution of trials .

Gotcha, well if LL is worth anything with so much more work to be done, and $CYDY in a piss poor position to receive anything financing wise, ESPECIALLY when the SEC won't allow the last share registration to go effective, it looks grim.